CoQ10 Combination Therapy to Reduce Chemotherapy Toxicity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current chemotherapeutic agents for treating cancer cause severe side effects and there is a need for improved methods to treat oncological disorders with reduced side effects.

Innovation Solution

Administering Coenzyme Q10 (CoQ10) prior to and/or concurrently with chemotherapeutic agents to enhance treatment efficacy and reduce side effects, using various administration routes and dosing schedules.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If chemotherapeutic agents are administered to treat cancer, then tumor burden is reduced and survival time is improved, but severe side effects occur including nephrotoxicity, cardiotoxicity, and immune suppression

Engineering Contradiction:
Improvecancer treatment efficacyVSAvoidchemotherapy side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

CoQ10 acts as a protective intermediary substance that mitigates the harmful effects of chemotherapeutic agents on healthy tissues while preserving the anti-cancer activity. The patent administers CoQ10 before, during, or after chemotherapy to protect organs such as kidneys, heart, and immune system from drug-induced toxicity.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

CoQ10 is administered in advance of chemotherapy treatment to prepare and protect the body's healthy cells and organs before exposure to toxic chemotherapeutic agents. This preliminary supplementation ensures adequate levels of CoQ10 are present to counteract upcoming side effects.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If higher doses of chemotherapeutic agents are used to improve treatment response, then tumor growth inhibition is enhanced, but toxicity and side effects increase

Engineering Contradiction:
Improvetumor growth inhibitionVSAvoiddrug toxicity
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent transforms the harmful toxicity of chemotherapeutic agents into a beneficial therapeutic window by using CoQ10 to protect healthy tissues. This allows administration of higher effective doses of chemotherapy to maximize tumor killing while CoQ10 prevents damage to healthy cells, effectively converting the drug's harmful side effects into a protected state.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Reliability

If chemotherapy is administered to reduce tumor burden, then cancer progression is slowed, but patient quality of life deteriorates due to side effects

Engineering Contradiction:
Improvecancer progression controlVSAvoidpatient quality of life
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

CoQ10 serves as a mediator that preserves patient quality of life during chemotherapy treatment. By protecting healthy tissues from drug-induced damage, CoQ10 reduces symptoms such as fatigue, immune suppression, and organ dysfunction, allowing patients to maintain better quality of life while still receiving effective cancer treatment.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Improves response to chemotherapy by reducing tumor burden, inhibiting tumor growth, and increasing survival time with minimized side effects.

Implementation Method 1

CoQ10 is a popular nutritional supplement and can be found in capsule form in nutritional stores, health food stores, pharmacies, and the like, as a vitamin-like supplement to help protect the immune system through the antioxidant properties of ubiquinol, the reduced form of CoQ10.

Methodology Applied
Scientific EffectAntioxidant properties: Oxidation

Data Source

PatentEP4729063A2Treatment of cancer using coenzyme q10 combination therapies
Publication Date: 2026.04.22 BPGBIO INC
  • EP4729063A2 patent drawingFigure 1
  • EP4729063A2 patent drawingFigure 2
  • EP4729063A2 patent drawingFigure 3

AI summary

Presented herein are methods for the treatment of oncological disorders by the coadministration of CoQ10 formulations and chemotherapeutic agents and/or surgery. The CoQ10 formulations may be at least one of intravenous, topical, or by inhalation. The chemotherapeutic agents may be at least one of antimetabolites or anthracyclines. Coadministration of the CoQ10 formulations may be prior to, concurrent or substantially concurrent with, intermittent with or subsequent to the administration of the chemotherapy.